Serial 88697285
Live / Registered — Registered (as of 06 Apr 2021)
What this means for you
Registered since 06 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88697285
- Registration number
- 6316655
- Mark type
- Design / logo
- Filed
- 18 Nov 2019
- Published for opposition
- 12 May 2020
- Registered
- 06 Apr 2021
- Attorney of record
- Kevin O'Keefe
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents
Owner
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangzhou, CN
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangzhou, CN
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangzhou, CN
Prosecution history
- 07 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jan 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2021 — USE AMENDMENT FILED
- 26 Jan 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jan 2021 — TEAS STATEMENT OF USE RECEIVED
- 07 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 May 2020 — PUBLISHED FOR OPPOSITION
- 22 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER